Company Overview and News

1
IIM Kozhikode Placement 2018: Student bags whopping Rs 38.5 lakh salary, average package at Rs 17.8 lakh

2018-10-16 financialexpress
IIM Kozhikode Placement 2018: The Indian Institute of Management, Kozhikode recently concluded its final placement for the 2016-18 session. A total of 382 students participated in the placement process in which the male to female ratio was 73:27. Top companies like Amazon, Microsoft, Airtel, HDFC Bank, Mahindra & Mahindra, Reliance Industries were among the 178 recruiters that participated in this year’s placement process.
500325 AXB IBN RELIANCE 532215 AXBKY AXBA ICICIBANK SGO HDB AXISBANK 532174 500180 RIGD HDFCBANK RLNIY

 
Hunter Douglas: Smart Acquisitions Are Already Paying Off

2018-08-31 seekingalpha
The capex remains at an elevated level but will start to trend down from 2019 on.
HDG SGO HUNDP

 
Suzlon, JP Power, Divi’s results on Saturday

2018-08-03 thehindubusinessline
Saturday will see close to 35 companies declaring their April-June quarter financial performance. Among these are Aarti Industries, ACE, Andhra Petrochemicals, Divi’s Labs, India Glycols, Jaiprakash Power Ventures, JSW Holdings, Lloyds Steel, Munjal Auto Industries, Oswal Chemicals, Pratibha Industries, Paramount Communications, Relaxo Footwears, Saint Gobain, Sandhar Tech, Suzlon Energy, Vardhman Acrylics, Windsor Machines and Wockhardt.
524208 522029 520059 SUZLON INDIAGLYCO 532718 530517 PRATIBHA 532627 530555 WINDMACHIN 532667 AARTIIND 532642 ANDHRAPET SGO RELAXO PARACABLES JPPOWER 500201 JSWHL SUEL MUNJALAU 500012

 
Global stocks set for fourth week of gains as trade angst eases

2018-07-27 channelnewsasia
Global stocks rose on Friday as strong company earnings reports and an easing of transatlantic trade tensions on an agreement between the United States and Europe this week to try to cut trade barriers boosted investor confidence.
SGO

 
Global stocks gain as trade tensions ebb

2018-07-27 channelnewsasia
Global stocks rose on Friday as strong company earnings reports and an easing of transatlantic trade tensions on an agreement between the United States and Europe this week to try to cut trade barriers boosted investor confidence.
SGO

 
UPDATE 1-European shares head for longest winning streak in three years, M&A in focus

2018-05-11 reuters
LONDON, May 11 (Reuters) - European stocks traded in a narrow range on Friday but were set to seal their longest winning streak in over three years as fresh deal-making stole the spotlight from the tail-end of a busy earnings season.
SGO

 
Sudhir Mishra bags IIT Madras alumnus award

2018-04-29 freepressjournal.in
Mumbai : Sudhir Mishra, Director General (BrahMos) of DRDO, has been conferred with the Alumnus Award by Indian Institute of Technology (IIT)-Madras in Chennai on Thursday during the celebration of the 59th Institution Day – Founding of IIT Madras. IIT Madras has conferred DAA award on 12 achievers out of them seven are working in the fields of energy, communication, IT and Health management in the US, one in the field of education in Singapore and rest in India.
SGO

 
Saint Gobain: Re-Establishing Itself As A DGI Company With A Current 3% Dividend Yield

2018-03-25 seekingalpha
Saint Gobain increases its dividend once again, and only had to cut it during the global financial crisis.
SGO

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to EPA:SGO / SAINT GOBAIN on message board site Silicon Investor.

Seagull Energy SGO Seagull Energy SGO Seagull Energy SGO St. Helena Gold Mines SGOLY St. Helena Gold Mines SGOLY St. Helena Gold Mines SGOLY
TEII/cdn.otc Transgold Explorations u0026 Inv. Inc. TEII/cdn.otc Transgold Explorations u0026 Inv. Inc. TEII/cdn.otc Transgold Explorations u0026 Inv. Inc.